List of insiders holdings for PHASEBIO PHARMACEUTICALS INC C:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Thorp Clay Director |
2023-05-19 16:18:34 | 36,693 3,545,040 |
3,581,733 | Form 4 |
| 2 | ASTRAZENECA PLC Zeneca Inc. 10% Owner |
2018-10-29 13:03:38 | 3,004,554 0 |
3,004,554 | Form 13D |
| 3 | Hatteras Venture Advisors III LLC Hatteras Ventures Partners III LP Hatteras Venture Affiliates III Lp Hatteras Venture Partners I LP Catalysta Ventures LLC Venture Capital Multiplier Fund INGRAM ROBERT ALEXANDER LEE KENNETH B JR Reed Douglas MD Crumpler John 10% Owner |
2019-07-29 16:27:08 | 2,489,156 0 |
2,489,156 | Form 13D |
| 4 | Mow Jonathan P Chief Executive Officer |
2022-05-24 17:14:47 | 132,502 51,199 |
183,701 | Form 4 |
| 5 | Lee John Sang Chief Medical Officer |
2022-02-28 19:23:31 | 140,250 0 |
140,250 | Form 4 |
| 6 | Sharp John P Chief Financial Officer |
2022-05-24 17:12:42 | 65,767 0 |
65,767 | Form 4 |
| 7 | Hutson Nancy J Director |
2023-05-19 16:15:57 | 37,510 4,000 |
41,510 | Form 4 |
| 8 | Arnold Susan Elizabeth SVP, Technical Operations |
2022-05-24 17:15:27 | 41,236 0 |
41,236 | Form 4 |
| 9 | TUFTS LINDA Director |
2019-03-01 17:23:07 | 36,000 0 |
36,000 | Form 4 |
| 10 | Birchall Jonathan Chief Commercial Officer |
2022-05-24 17:13:06 | 20,000 0 |
20,000 | Form 4 |
| 11 | Klein Peter Justin Director |
2021-06-04 18:07:58 | 14,000 0 |
14,000 | Form 4 |
| 12 | Mukhopadhyay Bibhash Director |
2019-05-13 16:44:48 | 11,000 0 |
11,000 | Form 4 |
| 13 | HARRIGAN EDMUND Director |
2023-05-19 16:17:34 | 9,750 0 |
9,750 | Form 4 |
| 14 | Ballance David James VP, Research and Sci. Affairs |
2020-11-23 18:38:37 | 8,519 0 |
8,519 | Form 4 |
| 15 | Hanson Kristopher SVP and General Counsel |
2022-05-24 17:13:29 | 8,463 0 |
8,463 | Form 4 |
| 16 | York Michael VP, Corporate Development |
2021-05-24 18:10:24 | 7,059 0 |
7,059 | Form 4 |
| 17 | Loewy Caroline M Director |
2023-05-19 16:16:48 | 3,750 0 |
3,750 | Form 4 |
| 18 | Sapir Alex Director |
2023-05-19 16:17:17 | 3,750 0 |
3,750 | Form 4 |
| 19 | Humphries William D. Director |
2023-05-19 16:18:07 | 2,538 0 |
2,538 | Form 4 |
| 20 | Burkhardt Glen SVP of Human Resources |
2022-05-24 17:14:08 | 0 0 |
0 | Form 4 |
| 21 | NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd SANDELL SCOTT D KERINS PATRICK J BASKETT FOREST 10% Owner |
2022-11-04 16:42:40 | 0 0 |
0 | Form 13D |
| 22 | Rivers Tyrell Director |
2018-10-17 20:04:05 | 0 0 |
0 | Form 3 |
| 23 | NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd BARRETT M JAMES BARRIS PETER J BASKETT FOREST KERINS PATRICK J MOTT DAVID M SANDELL SCOTT D Viswanathan Ravi 10% Owner |
2022-11-04 16:42:40 | 0 0 |
0 | Form 13D |
| 24 | van den Broek Richard Director |
2023-05-19 16:18:54 | 0 0 |
0 | Form 4 |